We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+17.69%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$3.59B
AUM Growth
+$454M
Cap. Flow
-$12.8M
Cap. Flow %
-0.36%
Top 10 Hldgs %
30.05%
Holding
147
New
21
Increased
72
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$40.3M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$16.3M
3
PRLB icon
Protolabs
PRLB
+$4.34M
4
EPAY
Bottomline Technologies Inc
EPAY
+$2.21M
5
MGPI icon
MGP Ingredients
MGPI
+$2.04M

Top Sells

Rank Stock Value
1
STMP
Stamps.com, Inc.
STMP
+$69.7M
2
HCSG icon
Healthcare Services Group
HCSG
+$11.8M
3
MLAB icon
Mesa Laboratories
MLAB
+$10.3M
4
WAGE
WageWorks, Inc.
WAGE
+$10.1M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$2.62M

Sector Composition

Rank Sector Weight
1 Technology 30.56%
2 Industrials 24.76%
3 Healthcare 18.78%
4 Consumer Discretionary 8.19%
5 Consumer Staples 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIDS icon
101
OrthoPediatrics
KIDS
$595M
$440K 0.01%
+9,955
New +$379K
MA icon
102
Mastercard
MA
$493B
$420K 0.01%
1,785
-55
-3% -$11.8K
CDNA icon
103
CareDx
CDNA
$2.42B
$413K 0.01%
+13,095
New +$382K
PG icon
104
Procter & Gamble
PG
$339B
$410K 0.01%
3,940
– –
XYL icon
105
Xylem
XYL
$28.1B
$408K 0.01%
5,160
+350
+7% +$25.5K
CVX icon
106
Chevron
CVX
$366B
$403K 0.01%
3,274
– –
DLB icon
107
Dolby
DLB
$5.79B
$396K 0.01%
6,293
– –
GRMN
108
Garmin
GRMN
$60B
$395K 0.01%
4,570
– –
WPC icon
109
W.P. Carey
WPC
$16.4B
$380K 0.01%
4,952
– –
NEO icon
110
NeoGenomics
NEO
$2.13B
$379K 0.01%
+18,500
New +$321K
NSTG
111
DELISTED
NanoString Technologies, Inc.
NSTG
$375K 0.01%
+15,680
New +$360K
CDXS icon
112
Codexis
CDXS
$158M
$373K 0.01%
+18,170
New +$353K
INTC icon
113
Intel
INTC
$513B
$371K 0.01%
6,900
– –
CYRX icon
114
CryoPort
CYRX
$762M
$355K 0.01%
+27,485
New +$299K
ADBE icon
115
Adobe
ADBE
$105B
$354K 0.01%
1,330
– –
ROAD icon
116
Construction Partners
ROAD
$6.77B
$336K 0.01%
+26,330
New +$305K
HXL icon
117
Hexcel
HXL
$7.82B
$333K 0.01%
4,818
– –
WLDN icon
118
Willdan Group
WLDN
$1.3B
$331K 0.01%
+8,920
New +$317K
SLP icon
119
Simulations Plus
SLP
$371M
$320K 0.01%
+15,155
New +$303K
IBM icon
120
IBM
IBM
$224B
$315K 0.01%
2,338
– –
SSTI icon
121
SoundThinking
SSTI
$103M
$315K 0.01%
+8,170
New +$351K
OFLX icon
122
Omega Flex
OFLX
$312M
$306K 0.01%
+4,035
New +$277K
VEEV icon
123
Veeva Systems
VEEV
$37.4B
$304K 0.01%
2,400
– –
NVEE
124
DELISTED
NV5 Global
NVEE
$294K 0.01%
+19,840
New +$342K
ROP icon
125
Roper Technologies
ROP
$39.8B
$294K 0.01%
860
– –
2 3 4
5
6

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return

Conestoga Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Conestoga Capital Advisors held 147 positions worth $3.59B, up 14% from $3.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Conestoga Capital Advisors's Q1 2019 filing shows 21 new, 72 increased, 15 reduced and 3 closed positions. Its largest new stake was Axon Enterprise: 785,855 shares worth $42.8M. The largest sale was Stamps.com, Inc., an estimated $69.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • Conestoga Capital Advisors's largest Q1 2019 buy was Axon Enterprise: 785,855 shares worth $42.8M.
  • Conestoga Capital Advisors added most to Ligand Pharmaceuticals in Q1 2019, an estimated $16.3M increase.
  • Conestoga Capital Advisors's biggest Q1 2019 reduction was Healthcare Services Group, cutting an estimated $11.8M.
  • Conestoga Capital Advisors fully exited Stamps.com, Inc. in Q1 2019, selling an estimated $69.7M.
  • Conestoga Capital Advisors's ten largest holdings make up 30% of its $3.59B portfolio in Q1 2019.
  • Conestoga Capital Advisors opened 21 new positions and closed 3 in Q1 2019.
  • Conestoga Capital Advisors's portfolio value rose 14% quarter-over-quarter to $3.59B.

Based on Conestoga Capital Advisors's 13F filing for Q1 2019, filed 18 Apr 2019.